Lower dementia risk with different classes of antihypertensive medication in older patients. Issue 10 (October 2017)

• Record Type: Journal Article
• Authors: van Middelaar, Tessa; van Vught, Lonneke A.; van Charante, Eric P. Moll; Eurelings, Lisa S.M.; Ligthart, Suzanne A.; van Dalen, Jan W.; van den Born, Bert Jan H.; Richard, Edo; van Gool, Willem A.
• Is Part Of: Journal of hypertension. Volume 35:Issue 10(2017:Oct.)
• Publication Date: 2017-10
• Subjects: antihypertensive medication -- blood pressure -- dementia -- hypertension; Hypertension -- Periodicals; Hypertension -- Periodicals; 616.132005
• DOI: 10.1097/HJH.0000000000001411
• Languages: English
• ISSNs: 1473-5598

Abstract

Abstract : Objective: Use of antihypertensive medication (AHM) is potentially associated with a reduced risk of dementia. Both calcium channel blockers (CCBs) and angiotensin receptor blockers (ARBs) are suggested to have a more pronounced protective effect. We aimed to study the association between different classes of AHM and dementia in older people. Methods: A subgroup of community-dwelling older people using AHM included in the 'Prevention of Dementia by Intensive Vascular Care' randomized controlled trial was studied. Incident dementia rates in participants with different AHM classes (mono and combination therapy) were compared with dementia rates in participants with any other AHM. Results: At baseline, 1951 participants (55.3%) used AHM [mean age, 74.4 year (SD 2.5); mean SBP, 156.4 mmHg (SD 21.5)]. In total, 986 participants (50.5%) used β-blockers, 798 diuretics (40.9%), 623 angiotensin- converting enzyme inhibitors (31.9%), 522 CCBs (26.8%), and 402 ARBs (20.6%). After 6.7 years (interquartile range 6.0–7.3) of follow-up, 136 participants (7.0%) developed dementia. Both use of CCBs [hazard ratio 0.56, 95% confidence interval (95% CI) 0.36–0.87] and ARBs (hazard ratio 0.60, 95% CI 0.37–0.98) were independently associated with a decreased risk of dementia. The association of CCBs with dementia was most apparent in participants without a history of cardiovascular disease (hazard ratio 0.38, 95% CI 0.18–0.81) and with uncontrolled hypertension (hazard ratio 0.26, 95% CI 0.11–0.61). SBP was not significantly lower in participants using CCBs or ARBs. Conclusion: Both use of CCBs and ARBs are independently associated with a decreased risk of dementia in older people. Abstract : Supplemental Digital Content is available in the text